Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand
Conditions: Plasmodium Falciparum Malaria; Plasmodium Vivax Malaria Interventions: Other: Case Management and Follow-up; Other: Reactive focal mass drug administration (rfMDA) Sponsors: University of California, San Francisco; Center for Malariology, Parasitology, and Entomology; Tulane University School of Public Health and Tropical Medicine; University of Massachusetts, Amherst; Centers for Disease Control and Prevention Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2021 Category: Research Source Type: clinical trials